🟢 ProMIS Neurosciences is trading 5% up in pre-market — reason remains unclear

ProMIS Neurosciences is trading at $11.49, up 5.03% in pre-market; the reason for the gain remains unclear.

• No confirmed company announcement explaining the move was identified; the listed Roth Healthcare Opportunities Conference was scheduled for September 29.
• Supplied broad-market indicators were modestly positive, below the stated threshold for attributing the move to market sentiment.
• The available prior-session report also noted an after-hours rise without a confirmed late-breaking catalyst.